3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
10
Terminated
3
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Nasopharyngeal Carcinoma
20
Prostatic Neoplasms
7
Breast Neoplasms
7
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Esophageal Neoplasms
6
Rectal Neoplasms
4
Radiation Injuries
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
3
Nasopharyngeal Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Recurrence
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Radiation
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms
1
Interventions
Radiosurgery
12
Temozolomide
10
Radiotherapy
10
Magnetic Resonance Spectroscopy
7
Erlotinib Hydrochloride
6
Bevacizumab
6
Surgical Procedures, Operative
5
Pemetrexed
5
Gefitinib
5
Drug Therapy
5
Carboplatin
5
pyrotinib
4
icotinib
4
aumolertinib
4
Trastuzumab
3
Spermine Synthase
3
Radiation
3
Lomustine
3
Etoposide
3
Dexmedetomidine
3
Chlorotoxin
3
Carmustine
3
osimertinib
2
camrelizumab
2
apatinib
2
Tyrosine Kinase Inhibitors
2
Thiotepa
2
Surveys and Questionnaires
2
Sevoflurane
2
Propofol
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Brain Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT03027544
2017-01-23
TRBM
ChineseAMS
Phase NA
Unknown
150 enrolled